Clinical Use of Growth Factors in the Myelodysplasic Syndromes
- 1 May 1994
- journal article
- review article
- Published by Elsevier BV in The American Journal of the Medical Sciences
- Vol. 307 (5), 360-367
- https://doi.org/10.1097/00000441-199405000-00010
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemiaCancer, 1990
- The Myelodysplastic Syndromes: Current Approaches to TherapyAnnals of Internal Medicine, 1990
- Bone Marrow Transplantation for Patients with MyelodysplasiaAnnals of Internal Medicine, 1990
- The role of low-dose cytosine arabinoside and aggressive chemotherapy in advanced myelodysplastic syndromesCancer, 1989
- Randomized study of 13-cis retinoic acid v placebo in the myelodysplastic disordersBlood, 1988
- The role of aggressive chemotherapy in the treatment of the myelodysplastic syndromesBritish Journal of Haematology, 1986
- Myelodysplastic syndromes: a scoring system with prognostic significanceBritish Journal of Haematology, 1985
- Modifications in the classification of primary myelodysplastic syndromes: The addition of a scoring systemHematological Oncology, 1985
- Glucocorticoid Therapy in the Preleukemic Syndrome (Hemopoietic Dysplasia)Annals of Internal Medicine, 1980
- Refractory Anaemia with Excess of Myeloblasts in the Bone Marrow: a Clinical Trial of Androgens in 90 PatientsBritish Journal of Haematology, 1977